Cargando…

PNS250 How to Deal with COVID-19-Related Intercurrent Events on Trial Estimands for Patient-Reported Outcomes (PRO) Objectives

Detalles Bibliográficos
Autores principales:	Skaltsa, K., Ivanescu, C., Reaney, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834112/ http://dx.doi.org/10.1016/j.jval.2020.08.1694

Ejemplares similares

Rethinking intercurrent events in defining estimands for tuberculosis trials
por: Pham, Tra My, et al.
Publicado: (2022)

Translating questions to estimands in randomized clinical trials with intercurrent events
por: Stensrud, Mats J., et al.
Publicado: (2022)

Handling intercurrent events and missing data in non-inferiority trials using the estimand framework: A tuberculosis case study
por: Rehal, Sunita, et al.
Publicado: (2023)

Estimating and reporting treatment effects in clinical trials for weight management: using estimands to interpret effects of intercurrent events and missing data
por: Wharton, Sean, et al.
Publicado: (2021)

Estimands for factorial trials
por: Kahan, Brennan C., et al.
Publicado: (2022)

Intercurrent events in clinical research: the norm, not the exception
por: Rojas-Saunero, L. Paloma, et al.
Publicado: (2022)

Understanding estimands
por: Gogtay, Nithya Jaideep, et al.
Publicado: (2021)

Cerebral Meningitis (Intercurrent)
por: Hay, Walter
Publicado: (1875)

Intercurrent Remedies for Chronic Diseases
Publicado: (1889)

Estimands and Complex Innovative Designs
por: Collignon, Olivier, et al.
Publicado: (2022)

Evaluating how clear the questions being investigated in randomised trials are: systematic review of estimands
por: Cro, Suzie, et al.
Publicado: (2022)

Handling death as an intercurrent event in time to recovery analysis in COVID-19 treatment clinical trials
por: Li, Hong, et al.
Publicado: (2022)

What is an estimand & how does it relate to quantifying the effect of treatment on patient-reported quality of life outcomes in clinical trials?
por: Lawrance, Rachael, et al.
Publicado: (2020)

Estimands in epigenome-wide association studies
por: Kruppa, Jochen, et al.
Publicado: (2021)

Estimands—What they are and why they are important for pharmacometricians
por: Akacha, Mouna, et al.
Publicado: (2021)

Estimands in published protocols of randomised trials: urgent improvement needed
por: Kahan, Brennan C., et al.
Publicado: (2021)

Estimands: bringing clarity and focus to research questions in clinical trials
por: Clark, Timothy Peter, et al.
Publicado: (2022)

Why estimands are needed to define treatment effects in clinical trials
por: Keene, Oliver N., et al.
Publicado: (2023)

Eliminating Ambiguous Treatment Effects Using Estimands
por: Kahan, Brennan C, et al.
Publicado: (2023)

Marking 2-Years of New Thinking in Clinical Trials: The Estimand Journey
por: Fletcher, C., et al.
Publicado: (2022)

Re-randomisation trials in multi-episode settings: Estimands and independence estimators
por: Kahan, Brennan C, et al.
Publicado: (2022)

Estimands in cluster-randomized trials: choosing analyses that answer the right question
por: Kahan, Brennan C, et al.
Publicado: (2022)

Immunity against Helminths: Interactions with the Host and the Intercurrent Infections
por: Moreau, Emmanuelle, et al.
Publicado: (2010)

Some considerations on target estimands for health technology assessment
por: Remiro‐Azócar, Antonio
Publicado: (2022)

The risks and benefits of patients temporarily discontinuing medications in the event of an intercurrent illness: a systematic review protocol
por: Morden, Andrew, et al.
Publicado: (2015)

Gestational diabetes mellitus and the role of intercurrent type 2 diabetes on long-term risk of cardiovascular events
por: Sun, Jiyu, et al.
Publicado: (2021)

The Physical Examination of the Chest in Pulmonary Consumption and Its Intercurrent Diseases
Publicado: (1861)

Retrospective study on intercurrent pancreatitis with Babesia gibsoni infection in dogs
por: MASUDA, Misa, et al.
Publicado: (2019)

Diathesis and Cachexiæ during Intercurrent Attacks—The Importance of Their Recognition and Treatment
por: Winston, Geo. H.
Publicado: (1890)

On estimands and the analysis of adverse events in the presence of varying follow‐up times within the benefit assessment of therapies
por: Unkel, Steffen, et al.
Publicado: (2018)

Statistical methods and graphical displays of quality of life with survival outcomes in oncology clinical trials for supporting the estimand framework
por: Sakamaki, Kentaro, et al.
Publicado: (2022)

PNS86 How US Clinical Trials Are Being Reimagined in a COVID-19 World
por: Hildreth, C., et al.
Publicado: (2021)

Hypothetical Estimands in Clinical Trials: A Unification of Causal Inference and Missing Data Methods
por: Olarte Parra, Camila, et al.
Publicado: (2022)

Estimands to quantify prolonged hospital stay associated with nosocomial infections
por: Wolkewitz, Martin, et al.
Publicado: (2019)

Principles and recommendations for incorporating estimands into clinical study protocol templates
por: Lynggaard, Helle, et al.
Publicado: (2022)

Intercurrent and opportunistic infections in patients treated with biological agents: study hypothesis
por: Popescu, Ramona Ștefania, et al.
Publicado: (2014)

Treatment estimands in clinical trials of patients hospitalised for COVID-19: ensuring trials ask the right questions
por: Kahan, Brennan C., et al.
Publicado: (2020)

Functional Loss and Mortality in Randomized Clinical Trials for Amyotrophic Lateral Sclerosis: To Combine, or Not to Combine—That is the Estimand
por: van Eijk, Ruben P.A., et al.
Publicado: (2022)

Commentary: Estimands in cluster trials: thinking carefully about the target of inferenceand the consequences for analysis choice
por: Hemming, Karla, et al.
Publicado: (2022)

F250. DEPRESSION IN SCHIZOPHRENIA: CORRELATIONS WITH OBJECTIVE AND SUBJECTIVE QUALITY OF LIFE OUTCOMES
por: Harvey, Philip, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kj55g733gltk66sem67mjo3qmm